| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |